{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T12:03:17Z","timestamp":1781697797175,"version":"3.54.5"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,1,3]],"date-time":"2020-01-03T00:00:00Z","timestamp":1578009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,1,3]],"date-time":"2020-01-03T00:00:00Z","timestamp":1578009600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81570123"],"award-info":[{"award-number":["81570123"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. of Cardiovasc. Trans. Res."],"published-print":{"date-parts":[[2020,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>We performed a retrospective cohort study to analyze all 87 CAD patients with MGUS and 178 CAD patients without MGUS admitted in Zhongshan Hospital Fudan University from 2015 to 2017. Patients were followed up via regular patient visits or telephone, and the median follow-up period was 2.9\u00a0years. The end point of follow-up was the occurrence of major adverse cardiac events (MACE). CAD patients with MGUS had a higher risk of MACE than those without MGUS (log-rank <jats:italic>P<\/jats:italic>\u2009=\u20090.0015). After adjustment for other markers in the stepwise Cox regression model, MGUS was still related to the increasing risk of MACE incident (<jats:italic>P<\/jats:italic>\u2009=\u20090.002, HR\u2009=\u20092.308). Then, we constructed the nomogram based on the Cox regression model, and the concordance index (C-index) was 0.667. Hence, MGUS might be added into the risk model of CAD.<\/jats:p>","DOI":"10.1007\/s12265-019-09950-w","type":"journal-article","created":{"date-parts":[[2020,1,3]],"date-time":"2020-01-03T18:03:25Z","timestamp":1578074605000},"page":"806-812","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["MGUS Predicts Worse Prognosis in Patients with Coronary Artery Disease"],"prefix":"10.1007","volume":"13","author":[{"given":"Zhao","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifeng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianhong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yidan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lifan","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junbo","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,3]]},"reference":[{"key":"9950_CR1","unstructured":"Goldman, L., Schafer, A.I.. (2015). Goldman-Cecil medicine. 25th edition."},{"issue":"12","key":"9950_CR2","doi-asserted-by":"publisher","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","volume":"15","author":"SV Rajkumar","year":"2014","unstructured":"Rajkumar, S. V., Dimopoulos, M. A., Palumbo, A., Blade, J., Merlini, G., Mateos, M. V., et al. (2014). International myeloma working group updated criteria for the diagnosis of multiple myeloma. The Lancet Oncology, 15(12), e538\u2013e548.","journal-title":"The Lancet Oncology"},{"issue":"7","key":"9950_CR3","doi-asserted-by":"publisher","first-page":"859","DOI":"10.4065\/79.7.859","volume":"79","author":"RA Kyle","year":"2004","unstructured":"Kyle, R. A., Therneau, T. M., Rajkumar, S. V., Larson, D. R., Plevak, M. F., & Melton, L. R. (2004). Long-term follow-up of 241 patients with monoclonal gammopathy of undetermined significance: The original Mayo Clinic series 25 years later. Mayo Clinic Proceedings, 79(7), 859\u2013866.","journal-title":"Mayo Clinic Proceedings"},{"issue":"8","key":"9950_CR4","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1056\/NEJMoa01133202","volume":"346","author":"RA Kyle","year":"2002","unstructured":"Kyle, R. A., Therneau, T. M., Rajkumar, S. V., Offord, J. R., Larson, D. R., Plevak, M. F., et al. (2002). A long-term study of prognosis in monoclonal gammopathy of undetermined significance. The New England Journal of Medicine, 346(8), 564\u2013569.","journal-title":"The New England Journal of Medicine"},{"issue":"18","key":"9950_CR5","doi-asserted-by":"publisher","first-page":"4701","DOI":"10.1182\/blood-2010-10-299529","volume":"117","author":"M Dimopoulos","year":"2011","unstructured":"Dimopoulos, M., Kyle, R., Fermand, J. P., Rajkumar, S. V., San, M. J., Chanan-Khan, A., et al. (2011). Consensus recommendations for standard investigative workup: Report of the international myeloma workshop consensus panel 3. BLOOD., 117(18), 4701\u20134705.","journal-title":"BLOOD."},{"issue":"3","key":"9950_CR6","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1182\/blood-2005-03-1038","volume":"106","author":"SV Rajkumar","year":"2005","unstructured":"Rajkumar, S. V., Kyle, R. A., Therneau, T. M., Melton, L. R., Bradwell, A. R., Clark, R. J., et al. (2005). Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance. BLOOD., 106(3), 812\u2013817.","journal-title":"BLOOD."},{"issue":"24","key":"9950_CR7","doi-asserted-by":"publisher","first-page":"5126","DOI":"10.1182\/blood-2010-06-290668","volume":"116","author":"S Kumar","year":"2010","unstructured":"Kumar, S., Dispenzieri, A., Katzmann, J. A., Larson, D. R., Colby, C. L., Lacy, M. Q., et al. (2010). Serum immunoglobulin free light-chain measurement in primary amyloidosis: Prognostic value and correlations with clinical features. BLOOD., 116(24), 5126\u20135129.","journal-title":"BLOOD."},{"issue":"8","key":"9950_CR8","doi-asserted-by":"publisher","first-page":"3378","DOI":"10.1182\/blood-2005-07-2922","volume":"107","author":"A Dispenzieri","year":"2006","unstructured":"Dispenzieri, A., Lacy, M. Q., Katzmann, J. A., Rajkumar, S. V., Abraham, R. S., Hayman, S. R., et al. (2006). Absolute values of immunoglobulin free light chains are prognostic in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation. BLOOD., 107(8), 3378\u20133383.","journal-title":"BLOOD."},{"issue":"1","key":"9950_CR9","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1046\/j.1365-2141.2003.04433.x","volume":"122","author":"HJ Lachmann","year":"2003","unstructured":"Lachmann, H. J., Gallimore, R., Gillmore, J. D., Carr-Smith, H. D., Bradwell, A. R., Pepys, M. B., et al. (2003). Outcome in systemic AL amyloidosis in relation to changes in concentration of circulating free immunoglobulin light chains following chemotherapy. British Journal of Haematology, 122(1), 78\u201384.","journal-title":"British Journal of Haematology"},{"issue":"8","key":"9950_CR10","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/j.amjcard.2014.07.049","volume":"114","author":"E Shantsila","year":"2014","unstructured":"Shantsila, E., Wrigley, B., & Lip, G. Y. (2014). Free light chains in patients with acute heart failure secondary to atherosclerotic coronary artery disease. The American Journal of Cardiology, 114(8), 1243\u20131248.","journal-title":"The American Journal of Cardiology"},{"issue":"1","key":"9950_CR11","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3233\/CH-170289","volume":"68","author":"G Caimi","year":"2018","unstructured":"Caimi, G., Hopps, E., Carlisi, M., Montana, M., Galla, E., Lo, P. R., et al. (2018). Hemorheological parameters in monoclonal gammopathy of undetermined significance (MGUS). Clinical Hemorheology and Microcirculation, 68(1), 51\u201359.","journal-title":"Clinical Hemorheology and Microcirculation"},{"key":"9950_CR12","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3233\/CH-2008-1066","volume":"39","author":"BK Lee","year":"2008","unstructured":"Lee, B. K., Durairaj, A., Mehra, A., Wenby, R. B., Meiselman, H. J., & Alexy, T. (2008). Hemorheological abnormalities in stable angina and acute coronary syndromes. Clinical Hemorheology and Microcirculation, 39, 43\u201351.","journal-title":"Clinical Hemorheology and Microcirculation"},{"issue":"4","key":"9950_CR13","first-page":"441","volume":"35","author":"M Ercan","year":"2006","unstructured":"Ercan, M., Konukoglu, D., & Erdem, Y. T. (2006). Association of plasma viscosity with cardiovascular risk factors in obesity: An old marker, a new insight. Clinical Hemorheology and Microcirculation, 35(4), 441\u2013446.","journal-title":"Clinical Hemorheology and Microcirculation"},{"issue":"Suppl 46","key":"9950_CR14","first-page":"20","volume":"26","author":"E Cecchi","year":"2009","unstructured":"Cecchi, E., Mannini, L., & Abbate, R. (2009). Role of hyperviscosity in cardiovascular and microvascular diseases. Giornale Italiano di Nefrologia, 26(Suppl 46), 20\u201329.","journal-title":"Giornale Italiano di Nefrologia"},{"issue":"10","key":"9950_CR15","first-page":"999","volume":"89","author":"RS Vincent","year":"2014","unstructured":"Vincent, R. S. (2014). Multiple myeloma: 2014 update on diagnosis, risk-stratification, and management. American Journal of Hematology, 89(10), 999\u20131009.","journal-title":"American Journal of Hematology"},{"issue":"3","key":"9950_CR16","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1056\/NEJMoa1709974","volume":"378","author":"RA Kyle","year":"2018","unstructured":"Kyle, R. A., Larson, D. R., Therneau, T. M., Dispenzieri, A., Kumar, S., Cerhan, J. R., et al. (2018). Long-term follow-up of monoclonal gammopathy of undetermined significance. The New England Journal of Medicine, 378(3), 241\u2013249.","journal-title":"The New England Journal of Medicine"},{"issue":"2","key":"9950_CR17","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1001\/jama.297.2.169","volume":"297","author":"K Bibbins-Domingo","year":"2007","unstructured":"Bibbins-Domingo, K., Gupta, R., Na, B., Wu, A. H., Schiller, N. B., & Whooley, M. A. (2007). N-terminal fragment of the prohormone brain-type natriuretic peptide (NT-proBNP), cardiovascular events, and mortality in patients with stable coronary heart disease. JAMA., 297(2), 169\u2013176.","journal-title":"JAMA."},{"issue":"3","key":"9950_CR18","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1093\/eurheartj\/ehi036","volume":"26","author":"R Schnabel","year":"2005","unstructured":"Schnabel, R., Rupprecht, H. J., Lackner, K. J., Lubos, E., Bickel, C., Meyer, J., et al. (2005). Analysis of N-terminal-pro-brain natriuretic peptide and C-reactive protein for risk stratification in stable and unstable coronary artery disease: Results from the AtheroGene study. European Heart Journal, 26(3), 241\u2013249.","journal-title":"European Heart Journal"},{"issue":"10","key":"9950_CR19","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1515\/cclm-2012-0786","volume":"51","author":"E Giannitsis","year":"2013","unstructured":"Giannitsis, E., Spanuth, E., Horsch, A., Kleber, M. E., Koch, W., Grammer, T. B., et al. (2013). High-sensitivity cardiac troponin T and N-terminal pro-B-type natriuretic peptide predict mortality in stable coronary artery disease: Results from the Ludwigshafen risk and cardiovascular health (LURIC) study. Clinical Chemistry and Laboratory Medicine, 51(10), 2019\u20132028.","journal-title":"Clinical Chemistry and Laboratory Medicine"},{"issue":"6","key":"9950_CR20","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1177\/2048872615610869","volume":"5","author":"M Biener","year":"2016","unstructured":"Biener, M., Giannitsis, E., Lamerz, J., Mueller-Hennessen, M., Vafaie, M., & Katus, H. A. (2016). Prognostic value of elevated high-sensitivity cardiac troponin T levels in a low risk outpatient population with cardiovascular disease. European Heart Journal Acute Cardiovascular Care, 5(6), 409\u2013418.","journal-title":"European Heart Journal Acute Cardiovascular Care"},{"issue":"1","key":"9950_CR21","doi-asserted-by":"publisher","first-page":"e84483","DOI":"10.1371\/journal.pone.0084483","volume":"9","author":"A Mayr","year":"2014","unstructured":"Mayr, A., & Schmid, M. (2014). Boosting the concordance index for survival data\u2014A unified framework to derive and evaluate biomarker combinations. PLoS One, 9(1), e84483.","journal-title":"PLoS One"},{"issue":"7","key":"9950_CR22","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/j.jacc.2017.06.030","volume":"70","author":"D Lindholm","year":"2017","unstructured":"Lindholm, D., Lindback, J., Armstrong, P. W., Budaj, A., Cannon, C. P., Granger, C. B., et al. (2017). Biomarker-based risk model to predict cardiovascular mortality in patients with stable coronary disease. Journal of the American College of Cardiology, 70(7), 813\u2013826.","journal-title":"Journal of the American College of Cardiology"},{"issue":"3","key":"9950_CR23","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1093\/eurheartj\/ehv320","volume":"37","author":"M Roffi","year":"2016","unstructured":"Roffi, M., Patrono, C., Collet, J. P., Mueller, C., Valgimigli, M., Andreotti, F., et al. (2016). 2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European society of cardiology (ESC). European Heart Journal, 37(3), 267\u2013315.","journal-title":"European Heart Journal"},{"issue":"10","key":"9950_CR24","doi-asserted-by":"publisher","first-page":"715","DOI":"10.7326\/M16-2562","volume":"166","author":"JW Pickering","year":"2017","unstructured":"Pickering, J. W., Than, M. P., Cullen, L., Aldous, S., Ter Avest, E., Body, R., et al. (2017). Rapid rule-out of acute myocardial infarction with a single high-sensitivity cardiac troponin T measurement below the limit of detection: A collaborative meta-analysis. Annals of Internal Medicine, 166(10), 715\u2013724.","journal-title":"Annals of Internal Medicine"},{"issue":"3","key":"9950_CR25","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.carrev.2016.02.012","volume":"17","author":"G Niccoli","year":"2016","unstructured":"Niccoli, G., Conte, M., Marchitti, S., Montone, R. A., Fracassi, F., Grippo, R., et al. (2016). NT-proANP and NT-proBNP circulating levels as predictors of cardiovascular outcome following coronary stent implantation. Cardiovascular Revascularization Medicine, 17(3), 162\u2013168.","journal-title":"Cardiovascular Revascularization Medicine"},{"issue":"5","key":"9950_CR26","doi-asserted-by":"publisher","first-page":"472","DOI":"10.5603\/KP.2013.0093","volume":"71","author":"V Zdravkovic","year":"2013","unstructured":"Zdravkovic, V., Mladenovic, V., Colic, M., Bankovic, D., Lazic, Z., Petrovic, M., et al. (2013). NT-proBNP for prognostic and diagnostic evaluation in patients with acute coronary syndromes. Kardiologia Polska, 71(5), 472\u2013479.","journal-title":"Kardiologia Polska"},{"issue":"9","key":"9950_CR27","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1093\/clinchem\/48.9.1437","volume":"48","author":"JA Katzmann","year":"2002","unstructured":"Katzmann, J. A., Clark, R. J., Abraham, R. S., Bryant, S., Lymp, J. F., Bradwell, A. R., et al. (2002). Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: Relative sensitivity for detection of monoclonal light chains. Clinical Chemistry, 48(9), 1437\u20131444.","journal-title":"Clinical Chemistry"},{"issue":"8","key":"9950_CR28","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/j.amjcard.2014.07.049","volume":"114","author":"E Shantsila","year":"2014","unstructured":"Shantsila, E., Wrigley, B., & Lip, G. Y. (2014). (2014) free light chains in patients with acute heart failure secondary to atherosclerotic coronary artery disease. The American Journal of Cardiology, 114(8), 1243\u20131248.","journal-title":"The American Journal of Cardiology"},{"issue":"4","key":"9950_CR29","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1161\/01.CIR.101.4.385","volume":"101","author":"J Muller","year":"2000","unstructured":"Muller, J., Wallukat, G., Dandel, M., Bieda, H., Brandes, K., Spiegelsberger, S., et al. (2000). Immunoglobulin adsorption in patients with idiopathic dilated cardiomyopathy. CIRCULATION., 101(4), 385\u2013391.","journal-title":"CIRCULATION."},{"issue":"3","key":"9950_CR30","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.clinbiochem.2014.11.006","volume":"48","author":"B Uggla","year":"2015","unstructured":"Uggla, B., & Nilsson, T. K. (2015). Whole blood viscosity in plasma cell dyscrasias. Clinical Biochemistry, 48(3), 122\u2013124.","journal-title":"Clinical Biochemistry"},{"issue":"1","key":"9950_CR31","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3233\/CH-131691","volume":"55","author":"HC Kwaan","year":"2013","unstructured":"Kwaan, H. C. (2013). Hyperviscosity in plasma cell dyscrasias. Clinical Hemorheology and Microcirculation, 55(1), 75\u201383.","journal-title":"Clinical Hemorheology and Microcirculation"},{"issue":"21","key":"9950_CR32","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1001\/jama.282.21.2035","volume":"282","author":"AM Malek","year":"1999","unstructured":"Malek, A. M., Alper, S. L., & Izumo, S. (1999). Hemodynamic shear stress and its role in atherosclerosis. JAMA., 282(21), 2035\u20132042.","journal-title":"JAMA."},{"issue":"13","key":"9950_CR33","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1056\/NEJMoa054494","volume":"354","author":"RA Kyle","year":"2006","unstructured":"Kyle, R. A., Therneau, T. M., Rajkumar, S. V., Larson, D. R., Plevak, M. F., Offord, J. R., et al. (2006). Prevalence of monoclonal gammopathy of undetermined significance. The New England Journal of Medicine, 354(13), 1362\u20131369.","journal-title":"The New England Journal of Medicine"},{"issue":"9727","key":"9950_CR34","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1016\/S0140-6736(10)60482-5","volume":"375","author":"A Dispenzieri","year":"2010","unstructured":"Dispenzieri, A., Katzmann, J. A., Kyle, R. A., Larson, D. R., Melton, L. R., Colby, C. L., et al. (2010). Prevalence and risk of progression of light-chain monoclonal gammopathy of undetermined significance: A retrospective population-based cohort study. LANCET., 375(9727), 1721\u20131728.","journal-title":"LANCET."},{"issue":"1","key":"9950_CR35","doi-asserted-by":"publisher","first-page":"e6","DOI":"10.1016\/S2352-3026(14)00041-6","volume":"2","author":"SV Rajkumar","year":"2015","unstructured":"Rajkumar, S. V. (2015). Risk of progression in MGUS. Lancet Haematol., 2(1), e6\u2013e7.","journal-title":"Lancet Haematol."}],"updated-by":[{"DOI":"10.1007\/s12265-020-09971-w","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2020,3,26]],"date-time":"2020-03-26T00:00:00Z","timestamp":1585180800000}}],"container-title":["Journal of Cardiovascular Translational Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12265-019-09950-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12265-019-09950-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12265-019-09950-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,2]],"date-time":"2021-01-02T01:11:05Z","timestamp":1609549865000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12265-019-09950-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,3]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["9950"],"URL":"https:\/\/doi.org\/10.1007\/s12265-019-09950-w","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s12265-020-09971-w","asserted-by":"object"}]},"ISSN":["1937-5387","1937-5395"],"issn-type":[{"value":"1937-5387","type":"print"},{"value":"1937-5395","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,3]]},"assertion":[{"value":"28 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2020","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The captions to Figures 1\u20134 in this article as originally published were mismatched with the figures themselves.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation at Zhongshan Hospital Fudan University and with the Helsinki Declaration of 1975, as revised in 2000 (5). Informed consent was obtained from all patients for being included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human Subjects\/Informed Consent Statement"}}]}}